Table 2.
Mixed mode (ME) maximum likelihood linear regression model test with log 10 HCV RNA as dependent variable
| Log 10 HCV RNA | Coef. | Std. Err. | z | P | 95% Conf. | Interval |
|---|---|---|---|---|---|---|
| Age |
0.011 |
0.021 |
0.50 |
0.614 |
-0.030 |
0.051 |
| Gender |
0.068 |
0.194 |
0.35 |
0.727 |
-0.313 |
0.448 |
| HCV genotype 1 |
0.543 |
0.178 |
3.04 |
0.002 |
0.194 |
0.893 |
| Advanced liver fibrosis |
-0.183 |
0.205 |
-0.89 |
0.372 |
-0.585 |
0.219 |
| ART |
-0.175 |
0.284 |
-0.62 |
0.537 |
-0.731 |
0.381 |
| CD4 cell count/mm3 |
0.000 |
0.000 |
-0.21 |
0.831 |
-0.001 |
0.000 |
| Previous HCV therapy |
0.378 |
0.185 |
2.05 |
0.041 |
0.016 |
0.740 |
| IL28B CC genotype |
0.331 |
0.168 |
1.96 |
0.050 |
0.001 |
0.660 |
| _cons | 5.229 | 1.047 | 5.00 | 0.000 | 3.178 | 7.281 |
Log likelihood = -95.223521, Wald chi2(8) = 18.96, P = 0.0151.
ART: Anti Retroviral Therapy; Clean IFU: HIV viremia undetectable follow-up, regardless of being on ART.